Evidence map›Paper›PMID 30535593›Full record

ArticleJournal of neuro-oncology2019

Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments.

Camilla B Mitchell, Bronte Black, Faith Sun, Wojciech Chrzanowski, Justin Cooper-White, Benois Maisonneuve, Brett Stringer, Bryan Day, Maté Biro, Geraldine M O'Neill

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Biomarkers of tumor invasiveness in proteomics (Review).International journal of oncology · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Research Advances in the Role of the Tropomyosin Family in Cancer.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Camilla B MitchellChildren's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, 2145, Australia.
Bronte BlackChildren's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, 2145, Australia.
Faith SunChildren's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, 2145, Australia.
Wojciech ChrzanowskiFaculty of Pharmacy, The University of Sydney, Sydney, NSW, 2006, Australia.
Justin Cooper-WhiteTissue Engineering and Microfluidics Group, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, 4072, Australia.
Benois MaisonneuveCSIRO, Manufacturing Flagship, Biomedical Manufacturing Program, Clayton, VIC, Australia.
Brett StringerQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Bryan DayQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Maté BiroEMBL Australia Single Molecule Science Node, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
Geraldine M O'NeillChildren's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, 2145, Australia. geraldine.oneill@health.nsw.gov.au.ORCID http://orcid.org/0000-0001-9997-8794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe brain is a very soft tissue. Glioblastoma (GBM) brain tumours are highly infiltrative into the surrounding healthy brain tissue and invasion mechanisms that have been defined using rigid substrates therefore may not apply to GBM dissemination. GBMs characteristically lose expression of the high molecular weight tropomyosins, a class of actin-associating proteins and essential regulators of the actin stress fibres and focal adhesions that underpin cell migration on rigid substrates.

methodsHere, we investigated how loss of the high molecular weight tropomyosins affects GBM on soft matrices that recapitulate the biomechanical architecture of the brain.

resultsWe find that Tpm 2.1 is down-regulated in GBM grown on soft substrates. We demonstrate that Tpm 2.1 depletion by siRNA induces cell spreading and elongation in soft 3D hydrogels, irrespective of matrix composition. Tpm 1.7, a second high molecular weight tropomyosin is also down-regulated when cells are cultured on soft brain-like surfaces and we show that effects of this isoform are matrix dependent, with Tpm 1.7 inducing cell rounding in 3D collagen gels. Finally, we show that the absence of Tpm 2.1 from primary patient-derived GBMs correlates with elongated, mesenchymal invasion.

conclusionsWe propose that Tpm 2.1 down-regulation facilitates GBM colonisation of the soft brain environment. This specialisation of the GBM actin cytoskeleton organisation that is highly suited to the soft brain-like environment may provide novel therapeutic targets for arresting GBM invasion.

Indexed as

Neoplasm InvasivenessAnimalsBrain NeoplasmsCell Line, TumorCell MovementExtracellular MatrixGene Knockdown TechniquesGlioblastomaHumansHydrogelsMiceMicroscopy, Atomic ForceSpheroids, CellularTropomyosinXenograft Model Antitumor AssaysHydrogelsTPM2 protein, humanTropomyosinBrain tumourGliomaInvasionMechanobiologyTropomyosin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.